Connect with us
AbbVie will present Phase III TEMPLE study results at the 2025 International Headache Congress, showing atogepant’s superior tolerability and efficacy over topiramate for migraine prevention. Atogepant...
Daiichi Sankyo presented new results on its DXd antibody-drug conjugates at WCLC25 in Barcelona, showcasing advances in small cell and non-small cell lung cancer. Highlights included...
Researchers at INCLIVA and partner universities studied 107 Chagas disease patients in Valencia over 15 years. They found high digestive involvement, poor cure rates with toxic...
Madrid has launched Cringenes, a 15-month pilot project for neonatal genomic screening to detect over 300 rare diseases in newborns. Involving 300 infants, the program uses...
A global analysis reveals declining cancer research funding since 2016, with investments concentrated in wealthy nations. The U.S. contributed 57% of $51.4B, while low-income countries received...
Bristol Myers Squibb’s COLLIGO-HCM real-world study shows Camzyos® (mavacamten) reduces LVOT obstruction and improves symptoms in diverse patients with obstructive hypertrophic cardiomyopathy. Results align with clinical...
Premium Food Group’s investment in Reploid Group AG fosters circular food production by recycling biogenic waste with soldier fly larvae. Reploid’s modular “ReFarmUnits” upcycle biomass into...
The U.S. Supreme Court ruled that district courts cannot reinstate NIH-canceled grants but can review the legality of Trump-era guidelines restricting DEI, gender identity, and COVID-19...
The Virgen del Rocío University Hospital, University of Seville, and Pablo de Olavide University launched an AI-driven project to identify sarcoma biomarkers. Using high-performance computing, the...
Researchers at Massachusetts General Hospital found that clusterin, a protein with stage-dependent effects, can protect neurons by reducing inflammation and preserving synapses, complementing anti-amyloid therapies. However,...
 |
|
 |  |
 |
|